Skip to content

Pacific Diabetes Technologies

8 viewers · 30d

Total raised

$5.4M

3 filings since 2025 · latest Debt filed

Cumulative raised
LAST ROUND
Debt · $3.4M
ROUNDS
3
INVESTORS
5
FOUNDED
2021
HQ
Portland, OR
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
8

AI overview

Updated

Pacific Diabetes Technologies, Inc. (PDT) is a pioneering company focused on developing advanced diabetes management devices aimed at streamlining treatment for individuals with insulin-dependent diabetes. Their innovative approach integrates multiple functions into a single device to enhance user experience and improve health outcomes.

What sets it apart

PDT distinguishes itself by offering a single-port device that amalgamates glucose monitoring and insulin delivery, significantly reducing the complexity of diabetes management.

Funding history

3 rounds
Debt+1Oct 6, 2025
Form D
+$2.9M$5.4M total
Debt+1Oct 6, 2025
Form D/A
+$3.4M$5.4M total
EquityMar 13, 2025
Form D
+$2.1M$2.1M total

Products

1 tracked

SynerG™ Device

Diabetes Management Device

The SynerG™ device is a revolutionary combination of continuous glucose monitoring and insulin delivery systems, designed to be worn as a single unit. This innovative device eliminates the necessity for separate devices, making diabetes management more efficient and less intrusive.

  • Combines CGM and insulin delivery functions
  • Single-port design for ease of use
  • Minimizes the need for multiple insertion sites
  • User-friendly interface for real-time data tracking